Predicting response to neoadjuvant chemotherapy with liquid biopsies and multiparametric MRI in patients with breast cancer
Liquid Biopsy , , 2024
A comparative study of MassARRAY and GeneXpert assay in detecting rifampicin resistance in tuberculosis patients’ clinical specimens
Infectious Disease , , 2024
Prediction of outcomes for high-count monoclonal B lymphocytosis using an epigenetic and immunogenetic signature
Methylation , , 2024
Haplotype phasing of CYP2D6: an allelic ratio method using Agena MassARRAY data
PGx , , 2023
The emergence of RAS mutations in patients with RAS wild-type mCRC receiving cetuximab as first-line treatment: a noninterventional, uncontrolled multicenter study
Liquid Biopsy , , 2023
Detection and Correction of Sample Misidentifications in a Biobank Using the MassARRAY System and Genomic Information
Contact our Customer Support team for assistance with Agena Bioscience’s products and services. For general inquiries or questions, please visit our Contact Us page.
Close 
